Events

On November 20, 2019, Glumo successfully graduated from the first Bronco Venture Accelerator at Santa Clara University. Pictured is Navid Shaghaghi, one of our founders, and Morgan Slain, Founder and Director of the Bronco Venture Accelerator.

In august of 2019, our abstract was published in the Abstracts of the 2019 Annual Meeting of the German Society of Biomedical Engineering (Volume 64: Issue 2). Our abstract can be found on page 125 of this Biomedical Engineering Journal.

Dr. Zhang, one of the Glumo founders, attended the 2019 BMT conference that was held at the University of Frankfurt in Germany. There, Dr.Zhang presented our findings, focusing on how infrared light interacts with glucose molecules. Dr. Zhang was one of three presenters from the United States and one of two who focused on medical devices.

Formed by Santa Clara University and its Ciocca Center for Innovation and Entrepreneurship, the new Bronco Venture Accelerator combines the hands-on learning and growth for founders that traditional accelerators offer with the resources of the Santa Clara community.

The Accelerator invites startups run by people affiliated with SCU - the cohort currently includes students, alumni, and even two faculty - to apply to receive five months of weekly hands-on workshops, mentoring sessions, and $10,000 for business capital. In November, they will hold Demo Day, where Navid Shaghaghi and 11 others will pitch their ideas to Silicon Valley venture capitalists and angel investors.

The future of tracking blood glucose levels is noninvasive and pain-free!

No more troublesome finger pricks. Real-time glucose results.
Personalized and interactive graphs.

About Us

What is Glumo?

Unlike standard single droplet blood glucose meters which require actual blood samples, GluMo uses infrared (IR) light to measure the amount of glucose in the user's blood without drawing any blood. Furthermore, GluMo continuously takes measurements and wirelessly updates the user's medical file. The file, which is in the form of a secure website, contains timestamped glucose level measurements, graphs, and even predictions of the user's near future glucose levels based on learned trends of the user's actual glucose levels over time. Our goal for the near future is to shrink the technology's physical size to a system on a chip which can then be integrated into currently existing wearables which have IR sensors such as smart watches.

Why Glumo?

The current method fr monitoring blood glucose levels requires a drop of blood to be periodically obtained by pricking a fingertip with a retractable needle. However, this method is invasive, painful, and sometimes messy for the users. It can also cause infections over time with regular use due to the usage of unsterilized needles, repeated usage of needles which were designed and manufactured for single usage, or the sharing of needles/prickers between patients.